Latest filing published 18 Mar 2026 for Spire Healthcare Group plc.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 5 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +5.1%Entry £2.35 · Close at T+365 £2.47
- -14.3%Entry £0.99 · Close at T+365 £0.85
- -38.4%Entry £1.61 · Close at T+365 £0.99
- -40.6%Entry £2.24 · Close at T+365 £1.33
- -47.5%Entry £2.37 · Close at T+365 £1.25
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Justin Ash: trading record in brief
Justin Ash appears in our data through filings on Spire Healthcare Group plc shares, published by RNS (LSE). Between 23 November 2017 and 17 March 2026, the trades on record add up to 15 filings.
Purchases make up the whole of the open-market record (6 purchases, €734k). Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 8 share grants and 1 option exercise.
In size, the median ticket on the buying side is €86k. Of 5 purchases, 2 formed part of a group of insiders buying within 30 days of each other. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. For 5 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 40% of cases, with a median move of -0.3%. Past outcomes like these are no guarantee of what comes next.
The record was last updated on 18 March 2026 with a share grant in Spire Healthcare Group plc. The most recent open-market purchase was published on 17 September 2024, 782 days ago. Between a trade and the moment it shows up on RNS (LSE), the median delay is 1 day. For comparison, UK MAR gives managers three business days to notify a trade. These figures are compiled from regulatory filings published by RNS (LSE). They describe what insiders did and are not a recommendation.
Companies and markets linked to Justin Ash
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 736,733 sharesOutside of trading venueISIN GB00BNLPYF73RNS:4975754c-90a7-4dc6-9f84-d96e37f028c7
- 1,818 shares@ £1.986.7% of flowOutside of trading venueISIN GB00BNLPYF73RNS:5709409-0
- 759,173 sharesXLONISIN GB00BNLPYF73RNS:5594900
- 65,896 sharesXLONISIN GB00BNLPYF73RNS:5575400-0
- 21,100 shares@ £2.362593.3% of flowXLONISIN GB00BNLPYF73RNS:5353142Canonical exit: 16 Dec 2024 (T+90)
- 542,575 sharesXLONISIN GB00BNLPYF73RNS:5106777-2
- 152,786 sharesXLONISIN GB00BNLPYF73RNS:5106777-0
- 1,818 shares@ £1.98XLONISIN GB00BNLPYF73FCA-NSM:4351138-0
- 543,750 sharesXLONISIN GB00BNLPYF73FCA-NSM:4304862-2
- 95,007 sharesXLONISIN GB00BNLPYF73FCA-NSM:4304862-0
- 21,006 shares@ £2.3754XLONFCA-NSM:4292727-0Canonical exit: 1 Jun 2022 (T+90)
- 49,554 shares@ £1.0098.0% of flowXLONFCA-NSM:LSE20190809130003_14183855_20200326185058154_29952-0Canonical exit: 6 Nov 2019 (T+90)
- 125,000 shares@ £1.599955.9% of flowXLONFCA-NSM:LSE20180809153647_13750398_20200330111404385_15916-0Canonical exit: 7 Nov 2018 (T+90)
- 46,500 shares@ £2.15218.0% of flowXLONFCA-NSM:LSE20180307095927_13557911_20200330111427861_24888Canonical exit: 4 Jun 2018 (T+90)
- 84,500 shares@ £2.36536.1% of flowXLONFCA-NSM:LSE20171124085441_13443082_20200330131534881_20276Canonical exit: 21 Feb 2018 (T+90)
15 of 15 declarations